COR

$330.840.09%0.31

Cencora Inc (COR)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$330.53

Offen:

$336.79

24-Stunden-Volumen:

1,347,722

Relatives Volumen:

1.18

Marktkapitalisierung:

$63.13B

Einnahmen:

$328.68B

Nettoeinkommen (Verlust:

$2.55B

KGV:

25.38

EPS:

$13.03

Netto-Cashflow:

$1.56B

1W Leistung:

+0.25%

1M Leistung:

+7.05%

6M Leistung:

+8.83%

1Y Leistung:

-2.06%

1-Tages-Spanne:

$0.00$0.00

1-Wochen-Bereich:

$320.06$340.19

52-Wochen-Spanne:

$244.82$377.54

Cencora Inc Aktie (COR) Unternehmensprofil

Firmenname

Cencora Inc

Sektor

Healthcare

Branche

Medical Distribution

Telefon

610-727-7000

Adresse

1 WEST FIRST AVENUE, CONSHOHOCKEN, USA

Mitarbeiter

51,000

Nächster Verdiensttermin

2026-11-04

Neueste SEC-Einreichungen

SEC

COR-Diskussionen auf X

COR vs. MCK, CAH, HSIC, AHG vergleichen

Aktien	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
COR Cencora Inc	$63.13B	$328.68B	$2.55B	$1.56B	$13.03
MCK Mckesson Corp	$115.96B	$403.43B	$5.10B	$5.41B	$38.47
CAH Cardinal Health Inc	$58.00B	$250.74B	$1.55B	$4.39B	$6.54
HSIC Henry Schein Inc	$9.46B	$13.38B	$418.00M	$391.00M	$3.31
AHG Akso Health Group Adr	$1.08B	$14.85M	-$136.07M	$7.25M	-$0.4726

Cencora Inc Aktie (COR) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-08-19	Eingeleitet	RBC Capital Mkts	Sector Perform
2026-04-28	Eingeleitet	William Blair	Mkt Perform
2026-01-29	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2026-01-22	Hochstufung	Jefferies	Hold → Buy
2025-12-09	Eingeleitet	Barclays	Overweight
2025-06-03	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-12-04	Resumed	Mizuho	Outperform
2024-09-18	Herabstufung	BofA Securities	Buy → Neutral
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2024-01-03	Eingeleitet	Barclays	Overweight
2023-12-14	Eingeleitet	Wells Fargo	Equal Weight
2023-03-31	Eingeleitet	Citigroup	Buy
2023-01-31	Resumed	Evercore ISI	Outperform
2022-10-11	Hochstufung	BofA Securities	Neutral → Buy
2022-08-22	Resumed	Morgan Stanley	Equal-Weight
2022-07-11	Herabstufung	Evercore ISI	Outperform → In-line
2022-06-07	Hochstufung	Deutsche Bank	Hold → Buy
2022-05-26	Hochstufung	Barclays	Equal Weight → Overweight
2022-04-12	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-04-01	Resumed	Credit Suisse	Outperform
2021-03-12	Resumed	Evercore ISI	In-line
2021-02-04	Hochstufung	Evercore ISI	In-line → Outperform
2021-02-02	Hochstufung	Cowen	Market Perform → Outperform
2021-01-06	Hochstufung	BofA Securities	Underperform → Neutral
2021-01-06	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-10	Herabstufung	Wells Fargo	Equal Weight → Underweight
2020-12-03	Eingeleitet	Mizuho	Neutral
2020-08-06	Hochstufung	Raymond James	Mkt Perform → Outperform
2020-07-15	Eingeleitet	Barclays	Underweight
2020-06-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-04-23	Resumed	Credit Suisse	Outperform
2020-04-16	Herabstufung	Raymond James	Outperform → Mkt Perform
2020-04-13	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-04-01	Hochstufung	JP Morgan	Neutral → Overweight
2020-03-17	Hochstufung	Citigroup	Neutral → Buy
2020-02-11	Herabstufung	BofA/Merrill	Buy → Underperform
2020-02-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2019-09-12	Eingeleitet	Deutsche Bank	Hold
2019-07-10	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2019-04-11	Eingeleitet	Guggenheim	Buy
2019-04-10	Herabstufung	BofA/Merrill	Buy → Underperform
2019-04-10	Herabstufung	Evercore ISI	Outperform → In-line
2019-02-11	Herabstufung	JP Morgan	Neutral → Underweight
2019-01-17	Eingeleitet	UBS	Buy
2018-12-10	Herabstufung	Jefferies	Buy → Hold
2018-10-26	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2018-09-20	Eingeleitet	Berenberg	Buy
2018-07-17	Resumed	Stifel	Hold
2018-04-09	Eingeleitet	MoffettNathanson	Buy
2018-03-12	Hochstufung	KeyBanc Capital Mkts	Sector Weight → Overweight
2018-03-12	Hochstufung	Raymond James	Mkt Perform → Outperform
2017-09-25	Eingeleitet	JP Morgan	Neutral
2017-09-22	Eingeleitet	William Blair	Outperform

Finanzdaten der Cencora Inc-Aktie (COR)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Revenue USD (M)	321,332.82	293,958.60	262,173.41	238,587.01	213,988.84
Cost of revenue USD (M)	309,854.28	284,048.57	253,213.92	230,290.64	207,045.62
Gross profit USD (M)	11,478.54	9,910.03	8,959.49	8,296.37	6,943.23
Operating expenses USD (M)	6,991.89	-	6,618.76	-	-
Operating income USD (M)	2,628.60	2,175.25	2,340.73	2,366.38	2,354.20
Income before tax USD (M)	2,258.34	2,003.98	2,160.84	2,183.06	2,221.86
Income tax expense USD (M)	690.52	484.70	428.26	516.52	677.25
Net income USD (M)	1,567.81	1,519.27	1,732.58	1,666.54	1,544.61
Basic EPS USD/shares	8.02	7.60	8.62	8.15	7.48
Diluted EPS USD/shares	7.96	7.53	8.53	8.04	7.39
Basic weighted shares shares (M)	193.82	198.50	202.51	208.47	205.92
Diluted weighted shares shares (M)	195.21	200.28	204.59	211.21	208.47
Selling, general and administrative USD (M)	6,493.84	5,661.11	5,309.98	4,848.96	3,594.25

Cencora Inc-Aktie (COR) Insiderhandel

GREENBERG LON RSep 16 '26
Director
Transaktion
Sale
Kosten
$321.30
#Aktien
1,280
Wert ($)
411,264
#Aktien Gesamt
17,128
Lon GreenbergSep 16 '26
Director
Transaktion
Proposed Sale
Kosten
$321.31
#Aktien
1,280
Wert ($)
411,282
#Aktien Gesamt
0
Battaglia SilvanaSep 11 '26
Former Officer
Transaktion
Proposed Sale
Kosten
$325.00
#Aktien
1,324
Wert ($)
430,300
#Aktien Gesamt
0
Cleary James FSep 04 '26
Former Officer
Transaktion
Proposed Sale
Kosten
$335.17
#Aktien
10,000
Wert ($)
3,351,656
#Aktien Gesamt
0
Krikorian LazarusSep 01 '26
SVP & Chief Accounting Officer
Transaktion
Sale
Kosten
$325.97
#Aktien
985
Wert ($)
321,080
#Aktien Gesamt
16,169
Battaglia SilvanaSep 01 '26
Former Officer
Transaktion
Proposed Sale
Kosten
$330.00
#Aktien
6,593
Wert ($)
2,175,690
#Aktien Gesamt
0
Campbell Elizabeth SAug 24 '26
Executive Vice President
Transaktion
Sale
Kosten
$324.12
#Aktien
11,300
Wert ($)
3,662,663
#Aktien Gesamt
19,455
Campbell Elizabeth SAug 24 '26
Officer
Transaktion
Proposed Sale
Kosten
$324.10
#Aktien
11,301
Wert ($)
3,662,663
#Aktien Gesamt
0
Cleary James FAug 06 '26
Officer
Transaktion
Proposed Sale
Kosten
$316.65
#Aktien
20,000
Wert ($)
6,333,096
#Aktien Gesamt
0
Tyler Lauren MJun 22 '26
Director
Transaktion
Buy
Kosten
$270.23
#Aktien
550
Wert ($)
148,626
#Aktien Gesamt
4,359

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
GREENBERG LON R	Director	Sep 16 '26	Sale	$321.30	1,280	411,264	17,128
Lon Greenberg	Director	Sep 16 '26	Proposed Sale	$321.31	1,280	411,282	0
Battaglia Silvana	Former Officer	Sep 11 '26	Proposed Sale	$325.00	1,324	430,300	0
Cleary James F	Former Officer	Sep 04 '26	Proposed Sale	$335.17	10,000	3,351,656	0
Krikorian Lazarus	SVP & Chief Accounting Officer	Sep 01 '26	Sale	$325.97	985	321,080	16,169
Battaglia Silvana	Former Officer	Sep 01 '26	Proposed Sale	$330.00	6,593	2,175,690	0
Campbell Elizabeth S	Executive Vice President	Aug 24 '26	Sale	$324.12	11,300	3,662,663	19,455
Campbell Elizabeth S	Officer	Aug 24 '26	Proposed Sale	$324.10	11,301	3,662,663	0
Cleary James F	Officer	Aug 06 '26	Proposed Sale	$316.65	20,000	6,333,096	0
Tyler Lauren M	Director	Jun 22 '26	Buy	$270.23	550	148,626	4,359

Cencora Inc Aktie (COR) Neueste Nachrichten

Oct 30, 2026

Cencora Gears Up to Report Q4 Results: How to Play the Stock? - Zacks Investment Research

Oct 30, 2026

Oct 28, 2026

Cencora Inc Lobbyists, 2026 - OpenSecrets

Oct 28, 2026

Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research

Oct 28, 2026

Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network - TradingView

Oct 28, 2026

Oct 27, 2026

Cencora reports fiscal results November 4. Cencora stock falls 1.26 percent - ad-hoc-news.de

Oct 27, 2026

Is American Oncology Network (AONC) Fully Valued Following Cencora's $2.4b Buyout Deal? - Yahoo Finance

Oct 23, 2026

Cencora, Inc. Estimates – NYSE:COR - TradingView

Oct 23, 2026

Baird raises target for Cencora stock from USD 373 to USD 375 - AD HOC NEWS

Oct 23, 2026

Oct 22, 2026

Cencora outlook cut to negative as Fitch flags leverage pressure - Traders Union

Oct 22, 2026

Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion - Pharmaceutical Commerce

Oct 22, 2026

Cencora: Doubles Down on Oncology With AON Acquisition; Fair Value Estimate Maintained - Morningstar

Oct 22, 2026

Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance

Oct 22, 2026

Oct 21, 2026

The Deal and Law360 cover McDermott’s role in American Oncology Network’s proposed acquisition by Cencora - McDermott Will & Schulte

Oct 21, 2026

4 Firms Steer Cencora's $2.4B American Oncology Acquisition - Law360

Oct 21, 2026

4 Firms Steer Cencora's $2.4B American Oncology Acquisition - Law360

Oct 21, 2026

Cencora making $2.4B acquisition as diversification push continues - The Business Journals

Oct 21, 2026

Global Stars Portfolio's Cencora Inc(COR) Holding History - GuruFocus

Oct 21, 2026

Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance

Oct 21, 2026

Oct 07, 2026

Deals tracker: Harbor Health to buy 27 Village Medical clinics - Modern Healthcare

Oct 07, 2026

Oct 21, 2026

Baird Adjusts Price Target on Cencora to $375 From $373 - marketscreener.com

Oct 21, 2026

Here’s How Much You Would Have Made Owning Cencora Stock In The Last 5 Years - Benzinga

Oct 21, 2026

Cencora (COR) to Acquire American Oncology Network in $2.4B Deal - GuruFocus

Oct 21, 2026

Cencora, Inc. signed a definitive agreement to acquire remaining 96% stake in American Oncology Network, Inc. from AEA Growth Equity Fund LP, managed by AEA Investors LP and others. - marketscreener.com

Oct 21, 2026

Form 8K Cencora Inc For: 21 October By Investing.com - Investing.com Nigeria

Oct 21, 2026

Cencora (COR) Agrees to Acquire American Oncology Network in $2. - GuruFocus

Oct 21, 2026

Cencora to Acquire American Oncology Network in $2.4 Billion Deal - citybiz

Oct 21, 2026

Cencora to buy cancer care provider American Oncology Network in $2.4B deal - Seeking Alpha

Oct 21, 2026

Cencora to Acquire American Oncology Network - Yahoo Finance

Oct 21, 2026

Cencora to acquire American Oncology Network for $2.4 billion - Investing.com

Oct 21, 2026

Cencora to acquire American Oncology Network in $2.4 billion deal - Yahoo Finance

Oct 21, 2026

Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology - Yahoo Finance

Oct 21, 2026

Oct 20, 2026

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Oct 20, 2026

Cencora stock: Cencora schedules November 4 results for Cencora stock - ad-hoc-news.de

Oct 20, 2026

Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance

Oct 20, 2026

Cencora stock price target raised to $380 by Argus on growth outlook - Investing.com Canada

Oct 20, 2026

Cencora stock price target raised to $380 by Argus on growth outlook - Investing.com

Oct 20, 2026

26 ETFs Add to Cencora (COR) Holdings on Oct. 16 - Yahoo Finance

Oct 20, 2026

Cencora Inc Lobbying Profile, 2006 - OpenSecrets

Oct 20, 2026

UBS cuts target to USD 400 for Cencora stock - ad-hoc-news.de

Oct 20, 2026

Cencora Inc. stock: drug distributor at EUR 303.60 ahead of the Xetra open - ad-hoc-news.de

Oct 20, 2026

Oct 19, 2026

Cencora stock: A 25.36 P/ E gives Cencora stock a valuation anchor - ad-hoc-news.de

Oct 19, 2026

Cencora stock trades at EUR 302.00 ahead of quarterly results - ad-hoc-news.de

Oct 19, 2026

Oct 18, 2026

Cencora Inc. Common Stock (COR) Company Profile - Pluang

Oct 18, 2026

ABC5748091 Bond Profile: Coupon and Redemption - TradingView

Oct 18, 2026

Oct 16, 2026

ABC6310086 Bond Profile: Coupon and Redemption - TradingView

Oct 16, 2026

Cencora (COR): 3 Reasons We Love This Stock - Yahoo Finance

Oct 16, 2026

Ähnlich wie COR

Cencora Inc (COR)

Cencora Inc Aktie (COR) Unternehmensprofil

COR vs. MCK, CAH, HSIC, AHG vergleichen

Cencora Inc Aktie (COR) Hochstufungen & Herabstufungen

Finanzdaten der Cencora Inc-Aktie (COR)

Cencora Inc-Aktie (COR) Insiderhandel

Cencora Inc Aktie (COR) Neueste Nachrichten

Cencora Gears Up to Report Q4 Results: How to Play the Stock? - Zacks Investment Research

Cencora Inc Lobbyists, 2026 - OpenSecrets

Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research

Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network - TradingView

Cencora reports fiscal results November 4. Cencora stock falls 1.26 percent - ad-hoc-news.de

Argus raises target for Cencora stock to USD 380.00 - ad-hoc-news.de

Argus raises target for Cencora stock to USD 380.00 - ad-hoc-news.de

Cencora, Inc. (COR) Stock forecasts - Yahoo Finance Singapore

Cencora's Q4 2026 Earnings: What to Expect - Barchart.com

Is American Oncology Network (AONC) Fully Valued Following Cencora's $2.4b Buyout Deal? - Yahoo Finance

Cencora, Inc. Estimates – NYSE:COR - TradingView

Baird raises target for Cencora stock from USD 373 to USD 375 - AD HOC NEWS

Cencora outlook cut to negative as Fitch flags leverage pressure - Traders Union

Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion - Pharmaceutical Commerce

Cencora: Doubles Down on Oncology With AON Acquisition; Fair Value Estimate Maintained - Morningstar

Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance

The Deal and Law360 cover McDermott’s role in American Oncology Network’s proposed acquisition by Cencora - McDermott Will & Schulte

4 Firms Steer Cencora's $2.4B American Oncology Acquisition - Law360

4 Firms Steer Cencora's $2.4B American Oncology Acquisition - Law360

Cencora making $2.4B acquisition as diversification push continues - The Business Journals

Global Stars Portfolio's Cencora Inc(COR) Holding History - GuruFocus

Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance

Deals tracker: Harbor Health to buy 27 Village Medical clinics - Modern Healthcare

Baird Adjusts Price Target on Cencora to $375 From $373 - marketscreener.com

Here’s How Much You Would Have Made Owning Cencora Stock In The Last 5 Years - Benzinga

Cencora (COR) to Acquire American Oncology Network in $2.4B Deal - GuruFocus

Cencora, Inc. signed a definitive agreement to acquire remaining 96% stake in American Oncology Network, Inc. from AEA Growth Equity Fund LP, managed by AEA Investors LP and others. - marketscreener.com

Form 8K Cencora Inc For: 21 October By Investing.com - Investing.com Nigeria

Cencora (COR) Agrees to Acquire American Oncology Network in $2. - GuruFocus

Cencora to Acquire American Oncology Network in $2.4 Billion Deal - citybiz

Cencora to buy cancer care provider American Oncology Network in $2.4B deal - Seeking Alpha

Cencora to Acquire American Oncology Network - Yahoo Finance

Cencora to acquire American Oncology Network for $2.4 billion - Investing.com

Cencora to acquire American Oncology Network in $2.4 billion deal - Yahoo Finance

Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology - Yahoo Finance

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Cencora stock: Cencora schedules November 4 results for Cencora stock - ad-hoc-news.de

Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance

Cencora stock price target raised to $380 by Argus on growth outlook - Investing.com Canada

Cencora stock price target raised to $380 by Argus on growth outlook - Investing.com

26 ETFs Add to Cencora (COR) Holdings on Oct. 16 - Yahoo Finance

Cencora Inc Lobbying Profile, 2006 - OpenSecrets

UBS cuts target to USD 400 for Cencora stock - ad-hoc-news.de

Cencora Inc. stock: drug distributor at EUR 303.60 ahead of the Xetra open - ad-hoc-news.de

Cencora stock: A 25.36 P/ E gives Cencora stock a valuation anchor - ad-hoc-news.de

Cencora stock trades at EUR 302.00 ahead of quarterly results - ad-hoc-news.de

Cencora Inc. Common Stock (COR) Company Profile - Pluang

ABC5748091 Bond Profile: Coupon and Redemption - TradingView

ABC6310086 Bond Profile: Coupon and Redemption - TradingView

Cencora (COR): 3 Reasons We Love This Stock - Yahoo Finance

Ähnlich wie COR